SARAH CARTER: Open Payments
NPI 1689051351 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 57 payments from 28 companies in 2025. Trend: 2023 $305 · 2024 $1,060 · 2025 $1,233
Food & beverage: $1,233
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $168 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| Janssen Biotech, Inc. | 5 | $116 |
| E.R. Squibb & Sons, L.L.C. | 6 | $106 |
| PFIZER INC. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| GENZYME CORPORATION | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
| Pharmacosmos Therapeutics Inc. | 1 | $37 |
Products named: OPDIVO, ENHERTU, KEYTRUDA, FRUZAQLA, ERLEADA, SARCLISA, PLUVICTO, LIBTAYO.
Industry payments across NC — which companies pay providers there.
